Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Research ministers met for a seminar in London this week to discuss how to improve the handling of European-level research. The solution lies in steady and targeted reforms to practices in Brussels.
Researchers in South America have a unique opportunity to advance their position in world science, provided they champion necessary reforms of universities and research agencies.
Debates on bioprospecting tend to be dominated by historical distrust and visions of new riches. Companies and countries alike need to recognize each other's needs, but remain realistic about the issues at stake.
Cancer patients in Italy are threatening their own survival through faith in a miracle cure. But the government is justified in sanctioning controlled tests of the therapy, even if it lacks a scientific basis.
Early next month, the population of Switzerland will start to vote on the abandonment of research using genetically modified animals and plants. Scientists have behaved commendably but to insufficient effect.
Scientific and medical enthusiasm for the potential contributions of germline gene therapy must not obscure the need for detailed debate about its potential consequences — or for careful monitoring and sensitive regulation.
France's scientific and technological structures have no choice but to undergo a revolution. The government must encourage a climate of competitiveness and risk-taking required to ensure a strong scientific future.
A meeting in Beijing should provide a welcome opportunity to move forward in debates about the ethics and science of eugenics. Western scientists and their hosts should make the most of it.
Frustration among French researchers at an apparent slowing down in promised reforms threatens to undermine an essential process. A less abrasive attitude on the government's part is essential.
The costs of preventing the barbarity of biological warfare are not only financial but also include intrusiveness, at home as well as abroad. There is an urgent need to shoulder those costs to ensure an effective ban.
Barring accidents, construction of the space station seems inevitable. Obstacles confront those hoping to achieve high-quality research there. There is a continuing need for close monitoring of priorities.
The practice by which some researchers restrict access to published data for a year has hitherto been accepted. Nature and Science are collaborating to investigate whether that acceptance should cease.